| 4.49 0.41 (10.05%) | 08-18 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 6.38 | 1-year : | 7.46 |
| Resists | First : | 5.46 | Second : | 6.38 |
| Pivot price | 0.96  |
|||
| Supports | First : | 2.17 | Second : | 0.13 |
| MAs | MA(5) : | 2.57 |
MA(20) : | 0.76 |
| MA(100) : | 40.6  |
MA(250) : | 106.29 |
|
| MACD | MACD : | 0 |
Signal : | -0.8 |
| %K %D | K(14,3) : | 83.6 |
D(3) : | 77.4 |
| RSI | RSI(14): 78 |
|||
| 52-week | High : | 285.44 | Low : | 0.13 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ HAO ] has closed above the upper band by 4.7%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 82.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 54 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 4.8 - 4.82 | 4.82 - 4.83 |
| Low: | 3.99 - 4.01 | 4.01 - 4.02 |
| Close: | 4.46 - 4.49 | 4.49 - 4.51 |
Haoxi Health Technology Limited, operating with its subsidiaries in China, specializes in providing digital marketing services. The company's offerings encompass online short video marketing, which it delivers to advertisers through its network of media partners, alongside custom-designed marketing strategies. These tailored solutions involve the careful planning, creation, distribution, and optimization of online advertisements across various digital platforms, all aimed at helping advertisers attract new customers, drive conversions, and cultivate consumer loyalty. Advertisements are strategically placed on leading online short video and social media platforms, including popular services like Toutiao, Douyin, WeChat, and Sina Weibo. Haoxi primarily serves an advertiser base within the healthcare industry. The company was founded in 2018 and is headquartered in Beijing, China.
Wed, 12 Aug 2026
Haoxi Health Technology Limited Announces 1-For-20 Reverse Share Split - Sahm
Tue, 14 Jul 2026
Haoxi Health's planned AI system will use digital humans and automated content - Stock Titan
Fri, 10 Jul 2026
Haoxi Health Technology jumps 36.9% as traders appear to focus on its post-split float and recent capital actions - Quiver Quantitative
Fri, 10 Jul 2026
Haoxi Health lines up $4 million share sale at $0.40 each - Stock Titan
Fri, 10 Jul 2026
Haoxi Health Technology Ltd Announces $4 Million Registered Direct Offering of Class A Ordinary Shares - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Communication Services
|
|
|
Industry:
Advertising Agencies
|
|
| Shares Out | 2 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 545 (K) |
| Shares Short P.Month | 151 (K) |
| EPS | -16.61 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 34.36 |
| Profit Margin | -6.5 % |
| Operating Margin | -16.8 % |
| Return on Assets (ttm) | -22.1 % |
| Return on Equity (ttm) | -16 % |
| Qtrly Rev. Growth | 41.2 % |
| Gross Profit (p.s.) | 1.07 |
| Sales Per Share | 22.46 |
| EBITDA (p.s.) | -3.72 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -3 (M) |
| Levered Free Cash Flow | -1 (M) |
| PE Ratio | -0.28 |
| PEG Ratio | 0 |
| Price to Book value | 0.13 |
| Price to Sales | 0.19 |
| Price to Cash Flow | -2.54 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|